PDS Biotechnology Corporation (PDSB)
NASDAQ:PDSB
Holding PDSB?
Track your performance easily

PDS Biotechnology (PDSB) Financial Statements

668 Followers

PDS Biotechnology Financial Overview

PDS Biotechnology's market cap is currently ―. The company's EPS TTM is $-1.226; its P/E ratio is -2.54; PDS Biotechnology is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -8.01M$ -9.43M$ -9.72M$ -9.78M$ -11.95M
EBITDA$ -7.71M$ -9.14M$ -9.45M$ -9.57M$ -11.76M
Net Income Common Stockholders$ -8.33M$ -10.60M$ -10.90M$ -10.85M$ -11.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 57.70M$ 66.60M$ 56.60M$ 54.30M$ 60.60M
Total Assets$ 60.50M$ 69.01M$ 59.39M$ 57.19M$ 63.73M
Total Debt$ 24.38M$ 24.11M$ 23.85M$ 23.60M$ 23.52M
Net Debt$ -33.32M$ -42.49M$ -32.75M$ -30.70M$ -37.08M
Total Liabilities$ 29.58M$ 31.82M$ 33.26M$ 32.70M$ 31.31M
Stockholders Equity$ 30.92M$ 37.18M$ 26.13M$ 24.48M$ 32.44M
Cash Flow-
Free Cash Flow$ -8.89M$ -9.94M$ -8.46M$ -7.18M$ -4.81M
Operating Cash Flow$ -8.86M$ -9.94M$ -8.46M$ -7.18M$ -4.81M
Investing Cash Flow$ -29.00K----
Financing Cash Flow$ -13.79K$ 20.01M$ 10.77M$ 802.33K$ 196.26K
Currency in USD

PDS Biotechnology Earnings and Revenue History

PDS Biotechnology Debt to Assets

PDS Biotechnology Cash Flow

PDS Biotechnology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis